IKENA ONCOLOGY INC. -

Ikena Oncology Reports Third Quarter 2024 Financial Results

07 نوفمبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology Reports Second Quarter 2024 Financial Results

08 أغسطس 2024 16:15:00 بحسب Nasdaq GlobeNewswire

UPDATE – Ikena Oncology Announces Strategic Update

28 مايو 2024 16:42:37 بحسب Nasdaq GlobeNewswire

Ikena Oncology Announces Strategic Update

28 مايو 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update

13 مايو 2024 16:45:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum

10 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results

12 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference

27 فبراير 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer

21 فبراير 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology Outlines Key Priorities and Provides Corporate Updates

18 يناير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results

09 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology to Present at Multiple November 2023 Investor Conferences

07 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology to Participate in September 2023 Investor Conferences

05 سبتمبر 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update

10 أغسطس 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction

07 أغسطس 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology to Participate in Upcoming Investor Conferences

24 مايو 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology Pipeline

15 مايو 2023 07:50:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology Announces $40 Million Underwritten Offering

15 مايو 2023 07:45:00 بحسب Nasdaq GlobeNewswire

Ikena Oncology to Participate in the Stifel 2023 Virtual Targeted Oncology Days

20 أبريل 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Ikena Oncology Shares Differentiation Profile of IK-930, a Novel Hippo-Pathway Inhibitor, Including Projected Therapeutic Index Advantages and Breadth of Patient Populations at AACR 2023 Annual Meeting

17 أبريل 2023 09:00:01 بحسب Nasdaq GlobeNewswire